BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2022 12:54:50 PM | Browse: 647 | Download: 2404
 |
Received |
|
2022-05-21 16:55 |
 |
Peer-Review Started |
|
2022-05-21 16:57 |
 |
First Decision by Editorial Office Director |
|
2022-07-13 00:05 |
 |
Return for Revision |
|
2022-07-13 14:30 |
 |
Revised |
|
2022-07-23 15:23 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-09-09 03:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-09-12 17:52 |
 |
Articles in Press |
|
2022-09-12 17:52 |
 |
Edit the Manuscript by Language Editor |
|
2022-09-07 13:18 |
 |
Typeset the Manuscript |
|
2022-09-27 00:10 |
 |
Publish the Manuscript Online |
|
2022-10-14 12:54 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mu-Qi Wang, Ya-Ping Li, Meng Xu, Yan Tian, Yuan Wu, Xin Zhang, Juan-Juan Shi, Shuang-Suo Dang and Xiao-Li Jia |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
31500650, 81902449 |
| Key Research & Development Program-Social Development of Shaanxi Province |
2020SF-063 |
| Shaanxi Key Research and Development Plans |
2021SF-227 |
|
| Corresponding Author |
Xiao-Li Jia, Doctor, Chief Doctor, Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157 Xiwu Road, Xincheng District, Xi’an 710004, Shaanxi Province, China. drjxl.123@xjtu.edu.cn |
| Key Words |
VCAN; Hepatocellular carcinoma; Hepatitis B virus; Immune checkpoints; Tumor microenvironment |
| Core Tip |
VCAN expression is significantly higher in hepatocellular carcinoma (HCC) tumor tissue than in adjacent tissue, and high VCAN level may be a possible biomarker for the diagnosis and prognosis of HCC. VCAN is associated with hepatitis B e antigen in hepatitis B virus infected patients. VCAN may play a role in HCC through the extracellular matrix signaling pathway and inflammatory immune response, and is a potential biomarker for immune checkpoint (programmed cell death protein 1/cytotoxic T lymphocyte antigen 4) inhibitors. |
| Publish Date |
2022-10-14 12:54 |
| Citation |
Wang MQ, Li YP, Xu M, Tian Y, Wu Y, Zhang X, Shi JJ, Dang SS, Jia XL. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors. World J Gastrointest Oncol 2022; 14(10): 1933-1948
|
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i10/1933.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i10.1933 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.